Medidata also unveiled a series of new AI-based solutions integrated on the Medidata Platform. By automating complex workflows, including the one-click import of eCOA questionnaires, Dot slashes study ...

Humans are inherently wired to care for one another. It’s what makes us human. Yet in our modern world, accessing that care has become complex. We believe the best health care is personal, connected, ...

In a groundbreaking study published in BME Frontiers, researchers from the University of California, Los Angeles (UCLA), in ...

Asciminib is the first-in-class allosteric inhibitor that specifically binds the BCR::ABL1 myristoyl pocket used to treat patients with Chronic Myeloid Leukemia (CML). The global incidence rate of CML ...

Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced its Simcyp® Simulator enabled physiologically-based pharmacokinetic (PBPK) modeling predictions ...

In the last 2 years, virtual reality and augmented reality have taken a step toward more practical applications in eye care.In 2024, Healio | OSN looked at this digital technology as it was making its ...

The University of Arkansas at Little Rock School of Nursing has received continued full approval for its Associate Degree Program from ...

DELRAY BEACH, Fla., Feb. 27, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Surgical Simulation Market is projected to grow from about USD 176.0 million in 2025 to USD 349.4 million by 2030 ...

Hundreds of Gulf Coast State College students gathered in anticipation Thursday for the groundbreaking of the new nursing and ...

Using the HelpMeSee Eye Surgery Simulator, a high-fidelity virtual reality platform with haptic feedback, trainees can perform hundreds of simulated MSICS procedures in a supportive learning ...

Artificial intelligence (AI) is rapidly transforming healthcare and medical education. From enhancing diagnostic accuracy and clinical decision-making to enabling virtual simulations and personalized ...

Consegna Pharma, Inc. ("Consegna" or the "Company") today announced that it has received written responses from the U.S. Food and Drug Administration (FDA) regarding its Type C meeting for CP217, the ...